Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Trinidad EM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Immunology, Vol 2 (2011)
Macrophages have crucial functions in initiating the inflammatory reaction in a strict temporal and spatial manner to provide a ‘clear-up’ response required for resolution. Hormonal peptides such as melanocortins modulate macrophage reactivity an
Externí odkaz:
https://doaj.org/article/60b61a6ca8f041e296f7e020a426e2d3
Autor:
Almaguer G; Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla 42183, Mexico., Almaguer-Vargas G; Plant Breeding Department, Horticulture Institute, Chapingo Autonomous University, Federal Highway Mexico-Texcoco km 38.5, Chapingo, Texcoco 56230, Mexico., Molina-Trinidad EM; Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla 42183, Mexico., Becerril-Flores MA; Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla 42183, Mexico., Montejano B; Department of Pharmacy, Hospital San José, Santiago de Querétaro 76180, Mexico., Madrigal-Santillan E; Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla 42183, Mexico., Hernández-Ceruelos A; Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla 42183, Mexico., Figueroa-Gutiérrez AH; Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla 42183, Mexico., Montejano E; Interdisciplinary Professional Unit of Biotechnology IPN, National Polytechnic Institute, Av. Acueducto, La Laguna Ticoman, Gustavo A. Madero, Mexico City 07340, Mexico., Montejano-Rodríguez JR; Institute of Health Sciences, Autonomous University of the State of Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla 42183, Mexico.
Publikováno v:
Plants (Basel, Switzerland) [Plants (Basel)] 2023 Nov 02; Vol. 12 (21). Date of Electronic Publication: 2023 Nov 02.
Autor:
Trinidad EM; Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain., Juan-Ribelles A; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain., Pisano G; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain., Castel V; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain., Cañete A; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain.; School of Medicine, University of Valencia, Valencia, Spain., Gut M; National Center for Genomic Analysis - Centre for Genomic Regulation (CNAG-CRG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Universitat Pompeu Fabra (UPF), Barcelona, Spain., Heath S; National Center for Genomic Analysis - Centre for Genomic Regulation (CNAG-CRG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Universitat Pompeu Fabra (UPF), Barcelona, Spain., Font de Mora J; Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 May 12; Vol. 13, pp. 1037342. Date of Electronic Publication: 2023 May 12 (Print Publication: 2023).
Autor:
Ciscar M; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Trinidad EM; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Perez-Chacon G; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Alsaleem M; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK., Jimenez M; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Jimenez-Santos MJ; Bioinformatics Unit, Structural Biology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Perez-Montoyo H; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Sanz-Moreno A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Vethencourt A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge, Barcelona, Spain., Toss M; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK., Petit A; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain., Soler-Monso MT; Pathology Department, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain., Lopez V; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Gomez-Miragaya J; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Gomez-Aleza C; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Dobrolecki LE; Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA., Lewis MT; Molecular and Cellular Biology and Radiology, The Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas, USA., Bruna A; Cancer Research UK Cambridge Centre, Cambridge, UK., Mouron S; Breast Cancer Clinical Research Unit, Clinical Research Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Quintela-Fandino M; Breast Cancer Clinical Research Unit, Clinical Research Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Al-Shahrour F; Bioinformatics Unit, Structural Biology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Martinez-Aranda A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.; Medical Oncology, Breast Unit, Catalan Institute of Oncology (ICO), University Hospital of Bellvitge, Barcelona, Spain., Sierra A; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain., Green AR; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK., Rakha E; Nottingham Breast Cancer Research Centre, Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK., Gonzalez-Suarez E; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Oncobell, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2023 Apr 11; Vol. 15 (4), pp. e16715. Date of Electronic Publication: 2023 Mar 07.
Autor:
Trinidad EM; Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain., Vidal E; Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain., Coronado E; Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain., Esteve-Codina A; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), , Barcelona , Spain., Castel V; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Universitat Pompeu Fabra (UPF), Barcelona 08002, Spain., Cañete A; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.; Universitat Pompeu Fabra (UPF), Barcelona 08002, Spain.; Pediatric Oncology Unit, La Fe University Hospital, Valencia, Spain., Gut M; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), , Barcelona , Spain., Heath S; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), , Barcelona , Spain., Font de Mora J; Laboratory of Cellular and Molecular Biology, Health Research Institute Hospital La Fe, Valencia, Spain.; Clinical and Translational Research in Cancer, Health Research Institute Hospital La Fe, Valencia, Spain.
Publikováno v:
Briefings in bioinformatics [Brief Bioinform] 2023 Jan 19; Vol. 24 (1).
Autor:
Pozos-Nonato S; Departamento de Ingeniería y Tecnología (Sección Farmacia), Facultad de Estudios Superiores Cuautitlán- Universidad Nacional Autónoma de México, Cuautitlán Izcalli, Estado de México, 54740, Mexico., Domínguez-Delgado CL; Departamento de Ingeniería y Tecnología (Sección Farmacia), Facultad de Estudios Superiores Cuautitlán- Universidad Nacional Autónoma de México, Cuautitlán Izcalli, Estado de México, 54740, Mexico.; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, Austin, TX 78712, USA., Campos-Santander KA; Departamento de Ingeniería y Tecnología (Sección Farmacia), Facultad de Estudios Superiores Cuautitlán- Universidad Nacional Autónoma de México, Cuautitlán Izcalli, Estado de México, 54740, Mexico., Benavides AA; Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, Austin, TX 78712, USA., Pacheco-Ortin SM; Departamento de Ciencias Químicas, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli, Estado de México, 54740, Mexico., Higuera-Piedrahita RI; Unidad de Investigación Multidisciplinaria-L 3, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Carretera Cuautitlán-Teoloyucan, Cuautitlán Izcalli, 54714, Mexico., Resendiz-González G; Unidad de Investigación Multidisciplinaria-L 3, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Carretera Cuautitlán-Teoloyucan, Cuautitlán Izcalli, 54714, Mexico., Molina-Trinidad EM; Área Académica de Medicina, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Ex-Hacienda de la Concepción, Tilcuautla, Hidalgo, 42160, Mexico.
Publikováno v:
Current pharmaceutical biotechnology [Curr Pharm Biotechnol] 2023; Vol. 24 (11), pp. 1397-1419.
Autor:
Gómez-Aleza C; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain., Nguyen B; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Yoldi G; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain., Ciscar M; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Barranco A; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain.; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Hernández-Jiménez E; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain., Maetens M; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Salgado R; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium., Zafeiroglou M; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain., Pellegrini P; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain., Venet D; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Garaud S; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Trinidad EM; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain., Benítez S; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain., Vuylsteke P; Department of Medical Oncology, Université Catholique de Louvain, CHU UCL, Namur, site Sainte-Elisabeth, Namur, Belgium., Polastro L; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Wildiers H; Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium., Simon P; Department of Obstetrics and Gynaecology, Erasme, Université Libre de Bruxelles, Brussels, Belgium., Lindeman G; Peter MacCallum Cancer Centre, The Walter and Eliza Hall Institute of Medical Research and The Royal Melbourne Hospital, Melbourne, VIC, Australia., Larsimont D; Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Van den Eynden G; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Velghe C; Clinical Trial Supporting Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Rothé F; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Willard-Gallo K; Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Michiels S; Service de Biostatistique et D'Epidémiologie, Gustave Roussy, CESP, U1018, Université Paris-Sud, Faculté de Médcine, Université Paris-Saclay, Villejuif, France., Muñoz P; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain., Walzer T; Centre International de Recherche en Infectiologie, CIRI, Inserm U1111, CNRS, Université Claude Bernard, Lyon, France., Planelles L; BiOncotech Therapeutics, Parc Cientific Universitat, Valencia, Spain., Penninger J; Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.; IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Azim HA Jr; Division of Hematology/Oncology, Department of Medicine, American University of Beirut, Beirut, Lebanon., Loi S; Peter MacCallum Cancer Centre, The Walter and Eliza Hall Institute of Medical Research and The Royal Melbourne Hospital, Melbourne, VIC, Australia., Piccart M; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Sotiriou C; Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. christos.sotiriou@bordet.be.; Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. christos.sotiriou@bordet.be., González-Suárez E; Oncobell, Bellvitge Biomedical Research Institute, IDIBELL, Barcelona, Spain. egonzalez@cnio.es.; Molecular Oncology, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. egonzalez@cnio.es.
Publikováno v:
Nature communications [Nat Commun] 2020 Dec 10; Vol. 11 (1), pp. 6335. Date of Electronic Publication: 2020 Dec 10.